Webinar Information and Registration

Ask the Expert:
Exploring Issues with Biosimilars in Health Systems

Thursday, March 20, 2014
1-2 pm EST

Register Now

After registration, you will receive an e-mail confirmation with instructions for joining the webinar.

Download Handout

Accreditation for Pharmacists

ACPEThe American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (activity # 0204-0000-14-462-L03-P).

This activity is provided free of charge. Participants must participate in the entire presentation, submit an enrollment code (announced during the webinar), and complete the course evaluation to receive continuing pharmacy education (CPE) credit. Participants will process CPE credit online at http://elearning.ashp.org/my-activities, with the option of printing a CPE certificate. CPE credit will be reported directly to CPE Monitor. View full CE processing instructions.

Methods and Format

This is a live web-based activity consisting of audio, presentation slides, and an activity evaluation tool.  A live webinar brings the presentation to you.  Listen to the speaker present in “real time” as you watch the slides on the screen.  You will have the opportunity to ask the speaker questions at the end of the program.  Please join the conference at least 5 minutes before the scheduled start time for important announcements.

Target Audience

This continuing pharmacy education activity was planned to meet the needs of pharmacists in a variety of practice settings, and it would be particularly beneficial for pharmacists, clinical specialists, pharmacy managers, leaders, and educators who are interested in biosimilars.

Webinar Overview

Biosimilars are biological medicines that are “highly similar” to an innovator biological product, but due to their complexity, are not the same as the innovator product. There are unique scientific, legislative, and safety issues associated with biosimilars.

The content for the live webinar is based on questions raised by participants in a recent educational symposium on this topic.  Time for questions and answers from the webinar audience will be provided at the end of the presentation.

Learning Objectives

After participating in this application-based educational activity, attendees should be able to

  • Compare and identify important differences between biosimilars and innovator products.
  • Discuss considerations for incorporating biosimilars into the health-system formulary.

Faculty